Medical device maker Boston Scientific (NYSE:BSX) announced recently that it has begun launching new sizes of its Rubicon Support Catheter in the United States. New 0.035" and 0.018" diameter catheters are aimed to help support guidewires for placing stents and other peripheral vascular products in patients suffering from complications of peripheral arterial disease.
Peripheral arterial disease, or PAD, affects around 27-million people around the globe, according to Boston Scientific. The disease can create blockages in blood vessels, leading to cramps, pain, or even amputation of limbs.
Boston Scientific Peripheral Interventions president Jeff Mirviss commented on the use of the company's new products, saying: "Support catheters can help physicians treat more patients by facilitating the crossing of complex lesions... By making a full range of diameters of Rubicon Support Catheters available, we are offering more choices to clinicians."
Previously, Boston Scientific had offered the Rubicon catheter in only a 0.014" diameter model. The newer widths will allow physicians more flexibility in treating a wider range of symptoms.
Fool contributor Dan Carroll has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.